Life-long Monitoring of Frail Patients With Chronic Diseases

NCT ID: NCT01608932

Last Updated: 2015-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

152 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether telemonitoring of frail patients with chronic diseases produces benefits in terms of reduced readmissions, improved health related quality of life, and improved health status. In addition, the trial evaluates the economic and organisational impact of the telemonitoring service and examines its acceptability by patients and health professionals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is designed to evaluate the impact of telemonitoring on the follow-up of elderly patients with one or more chronic diseases among heart failure, chronic obstructive pulmonary disease and diabetes. The particular target of patients selected has the particularity of being "frail" according to a set of social eligibility criteria, agreed by the clinicians participating at the study. General practitioners are the first clinicians in charge of managing these patients during the trial follow-up. The term of comparison is represented by a control group, followed by outpatient usual care.

From a clinical point of view, the trial will investigate how the remote monitoring of some clinical parameters contributes to reduce the access to healthcare facilities (emergency and planned hospitalization, bed-days, ER, specialist and GP visits), to improve the patients health-related quality of life and to reduce the anxiety about health conditions. A cost-effectiveness and cost-utility analysis will be carried out in order to determine if and how telemonitoring helps to limit the healthcare expenditure. The evaluation will deal also with organizational changes and task shift due to telemonitoring introduction and patients and professionals perception towards the service.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Chronic Diseases Among Diabetes Mellitus, Chronic Obstructive Pulmonary Diseases and Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Treatment as usual

Group Type NO_INTERVENTION

No interventions assigned to this group

Telemonitoring for frail patients with chronic diseases

Telemonitoring for frail patients with chronic diseases

Group Type EXPERIMENTAL

Telemonitoring for frail patients with chronic diseases

Intervention Type PROCEDURE

Patients are equipped with a telemonitoring kit that can be composed by a portable wrist clinic device, a digital weight scale and a glucometer for clinical parameters measuring, according to the pathologies of the patient. The equipment is completed by a gateway device for data transmission.

The patient can monitor a complete set of clinical parameters, such as pulse-oxymetry, heart rate, blood pressure, ECG, body weight and glycemia with a frequency set by the clinician in the personalized treatment plan. In the same protocol the clinician includes also the alarm thresholds that determine when the clinical measures are out-of-range. Data are transmitted to a regional eHealth centre where a group of operators keeps these information under control and alerts the general practitioner in case of worsening of symptoms.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telemonitoring for frail patients with chronic diseases

Patients are equipped with a telemonitoring kit that can be composed by a portable wrist clinic device, a digital weight scale and a glucometer for clinical parameters measuring, according to the pathologies of the patient. The equipment is completed by a gateway device for data transmission.

The patient can monitor a complete set of clinical parameters, such as pulse-oxymetry, heart rate, blood pressure, ECG, body weight and glycemia with a frequency set by the clinician in the personalized treatment plan. In the same protocol the clinician includes also the alarm thresholds that determine when the clinical measures are out-of-range. Data are transmitted to a regional eHealth centre where a group of operators keeps these information under control and alerts the general practitioner in case of worsening of symptoms.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 65 years
* Diagnosis of one or more of the following chronic diseases:

* Heart failure - diagnosis confirmed by echocardiogram or by a specialist assessment
* Type 1 or 2 diabetes - with HbA1C of 7.5 or greater in the previous 15 months
* Chronic Obstructive Pulmonary Disease (COPD) - diagnosis confirmed by spirometry and FEV1 ≤ 70% of predicted normal and/or FEV1/FVC ratio ≤ 70% or by a specialist assessment

* Have had a fall in the previous year or who are considered at high risk of falling
* Need home social care
* Have a caregiver who have difficulties to take care of him/her properly
* Cognitive impairment/confusion, but with caregiver able to use devices.

Exclusion Criteria

* Patient unable to use the telemonitoring equipment (alone and assisted)
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Commission

OTHER

Sponsor Role collaborator

Local Health Authorities n. 4

UNKNOWN

Sponsor Role collaborator

Local Health Authorities n. 7

UNKNOWN

Sponsor Role collaborator

Local Health Authorities n. 9

UNKNOWN

Sponsor Role collaborator

Local Health Authorities n. 12

UNKNOWN

Sponsor Role collaborator

Local Health Authorities n. 13

UNKNOWN

Sponsor Role collaborator

Local Health Authorities n. 16

UNKNOWN

Sponsor Role collaborator

Local Health Authorities n. 20

UNKNOWN

Sponsor Role collaborator

SIMG (Italian College of General Medicine)

UNKNOWN

Sponsor Role collaborator

Regione Veneto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicolò Seminara, MD

Role: PRINCIPAL_INVESTIGATOR

SIMG - LHA 9 of Treviso

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Local Heath Authority of Padova

Padua, Padova, Italy

Site Status

Local Health Authority of Pieve di Soligo

Pieve di Soligo, Treviso, Italy

Site Status

Local Health Authority of Treviso

Treviso, Treviso, Italy

Site Status

Local Health Authority of Mirano

Mirano, Venezia, Italy

Site Status

Local Heath Authority Veneziana

Venezia, Venezia, Italy

Site Status

Local Heath Authority of Verona

Verona, Verona, Italy

Site Status

Local Heath Authority of Thiene

Thiene, Vicenza, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

G.A. 250487 - Veneto WP8Cl10

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.